On Thursday, the Federal Trade Commission took action against alcohol addiction telehealth company Monument, affirming its promise to crack down on digital health companies’ misuse
VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused
VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to invite investors and
Dive Brief: Steris has agreed to sell its dental business to investment firm Peak Rock Capital for $787.5 million in cash, the companies said on
Dive Brief: The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering
How would you spend $13 billion in cash? Is biotech stale? And remember Dendreon? We cover all that and more this week on “The Readout
Share this article According to GlobalData, the migraine drugs market is set to be worth $18.6bn in 2030 globally. Credit: Krakenimages.com via Shutterstock. The National
Share this article Downstream processing is a crucial part of pharmaceutical drug development. The purification and filtration of active pharmaceutical ingredients (APIs) and pharmaceutical drugs
Share this article Alpine’s lead asset is povetacicept being developed for renal indications and autoimmune cytopenias. Image credit: Shutterstock/Tada Images. Vertex Pharmaceuticals has agreed to
This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday